Therapeutic plasma exchange and IVIG can significantly reduce biological age
Live Forever Club - 20-Aug-2024How TPE and IVIG could unlock the fountain of youth
Join the club for FREE to access the whole archive and other member benefits.
Independent biomedical research institute focused on aging
The Buck was a pioneer in research on aging, and now we’re a global leader in the field. We opened our doors in 1999, becoming the world’s only research institution singularly focused on the biology of aging, yielding insights into age-related diseases before they start. We hire scientists from a variety of disciplines to attack the problem from all sides because the answers we’re after won’t come from a single field. To enhance our process, we worked with world-renowned architect I.M. Pei to create a campus that literally would not allow our researchers to work in silos.
Visit website: https://www.buckinstitute.org/
buck-institute-for-research-on-aging
Details last updated 29-Aug-2019
Company focused on novel ketone-based therapies for the treatment of heart diseases
Education professional skilled in Research, Life Sciences, Genetics, Biochemistry, and Science
Director of the Buck Artificial Intelligence Platform & Stanford 1000 Immunomes Project
OBG-YN and Member Board Of Trustees at the Buck Institute for Research on Aging
Buck Fellow at Buck institute - studies mechanisms underlying the cellular aging process
Assistant Professor and Co-Founder & Director of Global Consortium for Reproductive Longevity & Equality at Buck Institute
How TPE and IVIG could unlock the fountain of youth
It could be a potential supplement for improving cancer immunotherapy
A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
While modifying immune cell populations, the drugs also increased ageing biomarkers
FAST is precise and works with different cell types and microscopes
Research sheds light on the benefits of calorie restriction
Supplementation reduced the buildup of senescent cells in the arteries of aged mice
Senolytic intervention helps to repair the protective barrier of the eyes
Collaboration of data and discovery to extend healthspan for everyone
Selectively inhibits problematic free radicals - potential breakthrough in treatment of chronic diseases & ageing
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Scans to know the eyeAge can provide an actionable evaluation of gero-protective therapeutics
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
The study is a caution for scientists engaging in self-experimentation with senolytics
Some really exciting developments with quite a few in clinical trials
Also announces move to Buck Institute for Research on Aging
Staring at gadget screens at night affects circadian clock and in turn lifespan
In yeast, increasing Tom70 delays ageing related mitochondrial dysfunction
Treatment options for diseases of aging - from the makers of metabolic switch
New class of senotherapeutic drugs that could possibly target various diseases and ageing